Panitumumab Interactions
There are 31 drugs known to interact with panitumumab, along with 5 disease interactions. Of the total drug interactions, 12 are major, and 19 are moderate.
- View all 31 medications that may interact with panitumumab
- View panitumumab disease interactions (5)
Most frequently checked interactions
View interaction reports for panitumumab and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- Activated Charcoal (charcoal)
- Adriamycin (doxorubicin)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Anti-D (RHO) Immunoglobulin (rho (d) immune globulin)
- AquADEKs (multivitamin with minerals)
- Aspirin Low Strength (aspirin)
- Avapro (irbesartan)
- Avastin (bevacizumab)
- Axiron (testosterone)
- Bentyl (dicyclomine)
- Casodex (bicalutamide)
- Cernevit (multivitamin)
- Childrens Chewable Multivitamins (multivitamin)
- Citrucel (methylcellulose)
- Clinolipid (fat emulsion)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Colace (docusate)
- Compazine (prochlorperazine)
- Constulose (lactulose)
- Copper (copper gluconate)
- Creon (pancrelipase)
- Cymbalta (duloxetine)
- Dextrose (glucose)
- Fentanyl Transdermal System (fentanyl)
- Paracetamol (acetaminophen)
- Retinol (vitamin a topical)
- Vitamin D3 (cholecalciferol)
Panitumumab disease interactions
There are 5 disease interactions with panitumumab which include:
- CV/electrolyte imbalance
- dermatologic toxicities
- ocular disorders
- pulmonary toxicity
- liver/renal impairment
Report options
QR code containing a link to this page
More about panitumumab
- panitumumab consumer information
- Compare alternatives
- Reviews (7)
- Side effects
- Dosage information
- During pregnancy
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.